Papatheodoridis, G. V. Et Al. 2018. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. JOURNAL OF HEPATOLOGY , vol.68, no.6 , 1129-1136.

Papatheodoridis, G. V., Sypsa, V., Dalekos, G., Yurdaydin, C., van Boemmel, F., Buti, M., ... Goulis, J.(2018). Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. JOURNAL OF HEPATOLOGY , vol.68, no.6, 1129-1136.

Papatheodoridis, George Et Al. "Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population," JOURNAL OF HEPATOLOGY , vol.68, no.6, 1129-1136, 2018

Papatheodoridis, George V. Et Al. "Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population." JOURNAL OF HEPATOLOGY , vol.68, no.6, pp.1129-1136, 2018

Papatheodoridis, G. V. Et Al. (2018) . "Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population." JOURNAL OF HEPATOLOGY , vol.68, no.6, pp.1129-1136.

@article{article, author={George V Papatheodoridis Et Al. }, title={Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population}, journal={JOURNAL OF HEPATOLOGY}, year=2018, pages={1129-1136} }